Docetaxel

Approved Uses

Docetaxel is primarily used to treat several specific forms of cancer that have reached an advanced stage or have spread to other parts of the body (metastatic). It is often prescribed when other treatments have not been effective.

Breast Cancer

It is used to treat patients with locally advanced or metastatic breast cancer. It may be given alone or in combination with other chemotherapy medications, particularly after previous treatments have failed.

Non-Small Cell Lung Cancer

Docetaxel is used for patients with advanced or metastatic non-small cell lung cancer. It is frequently used for cases that have not responded to platinum-based chemotherapy.

Prostate Cancer

This medication is used to treat metastatic prostate cancer that is resistant to hormone therapy. In these cases, it is typically administered alongside a steroid medication.

Stomach Cancer

It is used to treat advanced stomach (gastric) cancer, including cancer of the gastroesophageal junction. For this condition, it is usually combined with other chemotherapy drugs.

Head and Neck Cancer

Docetaxel is used as part of a treatment plan for patients with locally advanced squamous cell carcinoma of the head and neck.

Mechanism of Action

Docetaxel belongs to a class of medications called taxanes. It is designed to target and disrupt the process of cell division, which is how cancer cells grow and spread throughout the body.

Interfering with Microtubules

To divide into two new cells, a cell must build and then break down a framework of protein structures called microtubules. These microtubules act like a cellular skeleton, helping to organize and move genetic material during the division process.

Docetaxel works by binding to these microtubules and preventing them from being disassembled. This action results in the following:

• Cell Cycle Arrest: By stabilizing the microtubules and preventing them from breaking down, the drug effectively freezes the cell's internal machinery.
• Inhibition of Mitosis: Because the cell cannot complete the process of division (mitosis), it cannot create new cancer cells.
• Cell Death: When a cell is unable to complete its division cycle, it eventually dies.

Because cancer cells typically divide much faster than most healthy cells, they are more sensitive to the effects of docetaxel. By stopping this rapid growth, the medication helps to shrink tumors or prevent the cancer from spreading further.

Common Side Effects

Many people receiving docetaxel experience side effects. Common reactions include:

• Nausea, vomiting, diarrhea, or constipation
• Loss of appetite and changes in taste
• Feeling very tired or weak
• Muscle, bone, or joint pain
• Temporary hair loss
• Changes in the color or texture of fingernails or toenails
• Mouth or throat sores

Serious Side Effects

Some side effects can be severe and require immediate medical attention. These include:

• Low blood cell counts: This may lead to an increased risk of infection (fever, chills, sore throat), unusual bruising or bleeding, and anemia (extreme tiredness, pale skin).
• Fluid retention: Swelling of the hands, feet, or legs, and rapid weight gain.
• Allergic reactions: Rash, hives, itching, or difficulty breathing and swallowing.
• Neuropathy: Numbness, tingling, or burning sensations in the hands or feet.
• Vision changes: Blurred vision or loss of sight.
• Skin reactions: Redness, swelling, or peeling of the skin, particularly on the palms of the hands or soles of the feet.
• Liver problems: Yellowing of the skin or eyes and dark urine.

Because some formulations of docetaxel contain alcohol, patients may experience symptoms of intoxication, such as confusion or sleepiness, during or after the infusion.

Boxed Warnings

Docetaxel carries several serious warnings due to the potential for life-threatening complications. These risks are often higher in patients with impaired liver function.

• Low White Blood Cell Counts: This medication can severely decrease the number of white blood cells, which are necessary to fight infections. This can lead to serious or fatal infections.
• Severe Allergic Reactions: Some patients may experience intense allergic reactions, including low blood pressure, skin rashes, or breathing difficulties. Pre-treatment with corticosteroid medications is typically required to reduce this risk.
• Fluid Retention: Severe swelling and weight gain can occur, even with the use of preventative medications. This may lead to fluid accumulation around the heart or lungs.

Alcohol Content

Docetaxel formulations contain alcohol (ethanol). This may cause symptoms of alcohol intoxication during or after the infusion. Patients should be aware that this may affect their ability to drive or operate machinery for several hours following treatment. Healthcare providers may consider the alcohol content in patients who need to avoid alcohol or those taking other medications that interact with it.

Other Serious Precautions

• Vision Changes: Some patients may develop cystoid macular edema, a condition that causes blurred or decreased vision. Prompt eye examinations are necessary if vision changes occur.
• Lung Problems: New or worsening shortness of breath, cough, or fever may indicate serious lung inflammation, such as interstitial lung disease.
• Skin and Nail Reactions: Severe skin rashes, redness, or permanent hair loss (alopecia) have been reported. Changes in fingernails or toenails may also occur.
• Secondary Cancers: There is a small risk of developing other types of cancer, such as acute myeloid leukemia or non-Hodgkin lymphoma, after receiving docetaxel.
• Neurological Effects: Patients may experience sensations of numbness, tingling, or burning in the hands and feet (peripheral neuropathy).

Pregnancy

Docetaxel may cause fetal harm when administered to a pregnant woman. It is important to inform a healthcare provider if you are pregnant or planning to become pregnant before starting this medication. Because of the risk of birth defects or pregnancy loss, effective birth control is recommended during treatment and for a period after the final dose:

• For women: Use effective contraception during treatment and for 6 months after the last dose.
• For men: Use effective contraception if your partner can become pregnant during treatment and for 3 months after the last dose.

If pregnancy occurs during treatment, the patient should contact their doctor immediately to discuss the potential risks to the fetus. Some formulations of docetaxel also contain alcohol, which may be a consideration for some patients.

Breastfeeding

It is not known whether docetaxel passes into human breast milk. Because of the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for at least 1 week after the final dose of docetaxel. Patients should consult with their healthcare provider to determine the safest way to feed their infant during and after treatment.

Docetaxel is available as a concentrated solution for injection. It is not available in oral forms such as tablets or capsules. Before it is given to a patient, the medication is typically diluted into an intravenous fluid bag.

Key details regarding its form include:

• Administration: It is delivered directly into a vein through an IV line (infusion).
• Preparation: The liquid solution often contains alcohol (ethanol) to help dissolve the active drug ingredients.
• Setting: Because it requires precise preparation and medical monitoring, it is only administered in hospitals, clinics, or specialized infusion centers.

FDA Approval and Indications

Docetaxel is approved by the U.S. Food and Drug Administration (FDA) for the treatment of various malignancies, including:

• Breast cancer
• Non-small cell lung cancer
• Hormone-refractory prostate cancer
• Gastric (stomach) adenocarcinoma
• Squamous cell carcinoma of the head and neck

Boxed Warnings

The FDA has issued boxed warnings for docetaxel due to the risk of serious and potentially fatal adverse reactions. These warnings include:

• Toxic Death: Increased risk of treatment-related mortality in patients with abnormal liver function, those receiving higher doses, and patients with non-small cell lung cancer previously treated with platinum-based chemotherapy who receive docetaxel as a single agent.
• Hepatotoxicity: Severe liver impairment increases the risk of life-threatening complications.
• Neutropenia: A significant decrease in white blood cell counts, which can lead to severe infections.
• Hypersensitivity Reactions: Severe allergic reactions, including anaphylaxis, may occur.
• Fluid Retention: Severe peripheral edema and pleural effusion have been reported.

Safety Communications

The FDA has alerted healthcare professionals and patients that docetaxel formulations contain ethanol (alcohol). This may lead to symptoms of alcohol intoxication during or after the infusion. Patients are advised to avoid driving or operating machinery immediately following treatment.

Factors Affecting Cost

The cost of docetaxel is influenced by several variables, including the dosage required for a specific treatment plan and the frequency of administration. As a generic medication, docetaxel is typically less expensive than the brand-name version, Taxotere.

Administration and Insurance

Because docetaxel is administered intravenously by healthcare professionals in a hospital or clinic, the total cost often includes additional fees beyond the medication itself, such as:

• Professional fees for medical staff.
• Facility fees for the infusion center or hospital.
• Costs for supportive medications given during the infusion.

Most insurance providers, including Medicare and Medicaid, generally cover docetaxel when it is prescribed for FDA-approved indications. Patients should verify their specific out-of-pocket responsibilities, such as co-pays or deductibles, with their insurance provider. Financial assistance programs may be available through certain organizations for those who qualify.